SinTS has created a favorable accuracy for patient triage, particularly for patients with high-risk complaints such as chest pain and dyspnea, by using specific criteria of SpO2 and PEF for COPD patients, PetCO2 for HF patients, and cTnI for MI patients. The gene discussed is TNNI3; the disease is myocardial infarction.